Vulvar Adenocarcinoma — Trials

Vulvar Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Avacta Life Sciences Ltd
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02223975	Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease(Vulval VS)	suspended	—	200	Gloucestershire Hospitals NHS Foundation TrustOTHER	1	Aug 4, 2017	clinicaltrials

Data updated 23 days agoSource updated Aug 4, 2017source: clinicaltrials